|
1
|
Selzner N, Rudiger H, Graf R and Clavien
PA: Protective strategies against ischemic injury of the liver.
Gastroenterology. 125:917–936. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Uchida Y, Ke B, Freitas MC, Yagita H,
Akiba H, Busuttil RW, Najafian N and Kupiec-Weglinski JW: T-cell
immunoglobulin mucin-3 determines severity of liver
ischemia/reperfusion injury in mice in a TLR4-dependent manner.
Gastroenterology. 139:2195–2206. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peralta C, Jiménez-Castro MB and
Gracia-Sancho J: Hepatic ischemia and reperfusion injury: Effects
on the liver sinusoidal milieu. J Hepatol. 59:1094–1106. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Golen RF, van Gulik TM and Heger M:
The sterile immune response during hepatic ischemia/reperfusion.
Cytokine Growth Factor Rev. 23:69–84. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gomes KM, Bechara LR, Lima VM, Ribeiro MA,
Campos JC, Dourado PM, Kowaltowski AJ, Mochly-Rosen D and Ferreira
JC: Aldehydic load and aldehyde dehydrogenase 2 profile during the
progression of post-myocardial infarction cardiomyopathy: Benefits
of Alda-1. Int J Cardiol. 179:129–138. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma H, Guo R, Yu L, Zhang Y and Ren J:
Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial
ischaemia/reperfusion injury: Role of autophagy paradox and toxic
aldehyde. Eur Heart J. 32:1025–1038. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen CH, Ferreira JC, Gross ER and
Mochly-Rosen D: Targeting aldehyde dehydrogenase 2: New therapeutic
opportunities. Physiol Rev. 94:1–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen CH, Sun L and Mochly-Rosen D:
Mitochondrial aldehyde dehydrogenase and cardiac diseases.
Cardiovasc Res. 88:51–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoval-Sánchez B and Rodríguez-Zavala JS:
Differences in susceptibility to inactivation of human aldehyde
dehydrogenases by lipid peroxidation byproducts. Chem Res Toxicol.
25:722–729. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gomes KM, Campos JC, Bechara LR, Queliconi
B, Lima VM, Disatnik MH, Magno P, Chen CH, Brum PC, Kowaltowski AJ,
et al: Aldehyde dehydrogenase 2 activation in heart failure
restores mitochondrial function and improves ventricular function
and remodelling. Cardiovasc Res. 103:498–508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Doorn JA, Hurley TD and Petersen DR:
Inhibition of human mitochondrial aldehyde dehydrogenase by
4-hydroxynon-2-enal and 4-oxonon-2-enal. Chem Res Toxicol.
19:102–110. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guo R, Xu X, Babcock SA, Zhang Y and Ren
J: Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating
chronic alcohol-induced hepatic steatosis and inflammation through
regulation of autophagy. J Hepatol. 62:647–656. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CH, Budas GR, Churchill EN, Disatnik
MH, Hurley TD and Mochly-Rosen D: Activation of aldehyde
dehydrogenase-2 reduces ischemic damage to the heart. Science.
321:1493–1495. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Czaja MJ, Ding WX, Donohue TJ Jr, Friedman
SL, Kim JS, Komatsu M, Lemasters JJ, Lemoine A, Lin JD, Ou JH, et
al: Functions of autophagy in normal and diseased liver. Autophagy.
9:1131–1158. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
National Research Council, . Guide for the
care and use of laboratory animals. (8th). The National Academies
Press. (Washington, DC). 2011.
|
|
16
|
Ji W, Wei S, Hao P, Xing J, Yuan Q, Wang
J, Xu F and Chen Y: Aldehyde dehydrogenase 2 has cardioprotective
effects on myocardial ischaemia/reperfusion injury via suppressing
mitophagy. Front Pharmacol. 7:1012016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki S, Toledo-Pereyra LH, Rodriguez FJ
and Cejalvo D: Neutrophil infiltration as an important factor in
liver ischemia and reperfusion injury. Modulating effects of FK506
and cyclosporine. Transplantation. 55:1265–1272. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Z, Zhang X, Xiao Q, Ye S, Lai CH, Luo
J, Huang X, Wang W, Zeng C, Zhong Z, et al: Pretreatment donors
after circulatory death with simvastatin alleviates liver ischemia
reperfusion injury through a KLF2-dependent mechanism in rat. Oxid
Med Cell Longev. 2017:38619142017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cursio R, Colosetti P and Gugenheim J:
Autophagy and liver ischemia-reperfusion injury. Biomed Res Int.
2015:4175902015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhong W, Zhang W, Li Q, Xie G, Sun Q, Sun
X, Tan X, Sun X, Jia W and Zhou Z: Pharmacological activation of
aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic
steatosis and cell death in mice. J Hepatol. 62:1375–1381. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhu Q, He G, Wang J, Wang Y and Chen W:
Pre-treatment with the ALDH2 agonist Alda-1 reduces intestinal
injury induced by ischaemia and reperfusion in mice. Clin Sci
(Lond). 131:1123–1136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhong Z, Hu Q, Fu Z, Wang R, Xiong Y,
Zhang Y, Liu Z, Wang Y and Ye Q: Increased expression of aldehyde
dehydrogenase 2 reduces renal cell apoptosis during
ischemia/reperfusion injury after hypothermic machine perfusion.
Artif Organs. 40:596–603. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fu SH, Zhang HF, Yang ZB, Li TB, Liu B,
Lou Z, Ma QL, Luo XJ and Peng J: Alda-1 reduces cerebral
ischemia/reperfusion injury in rat through clearance of reactive
aldehydes. Naunyn Schmiedebergs Arch Pharmacol. 387:87–94. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Caraceni P, Domenicali M, Vendemiale G,
Grattagliano I, Pertosa A, Nardo B, Morselli-Labate AM, Trevisani
F, Palasciano G, Altomare E and Bernardi M: The reduced tolerance
of rat fatty liver to ischemia reperfusion is associated with
mitochondrial oxidative injury. J Surg Res. 124:160–168. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Horton JW and Walker PB: Oxygen radicals,
lipid peroxidation, and permeability changes after intestinal
ischemia and reperfusion. J Appl Physiol (1985). 74:1515–1520.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee H, Ko EH, Lai M, Wei N, Balroop J,
Kashem Z and Zhang M: Delineating the relationships among the
formation of reactive oxygen species, cell membrane instability and
innate autoimmunity in intestinal reperfusion injury. Mol Immunol.
58:151–159. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
van Golen RF, van Gulik TM and Heger M:
Mechanistic overview of reactive species-induced degradation of the
endothelial glycocalyx during hepatic ischemia/reperfusion injury.
Free Radic Biol Med. 52:1382–1402. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Traverso N, Menini S, Odetti P, Pronzato
MA, Cottalasso D and Marinari UM: Diabetes impairs the enzymatic
disposal of 4-hydroxynonenal in rat liver. Free Radic Biol Med.
32:350–359. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang Y, Yuan D, Yao W, Zhu Q, Liu Y,
Huang F, Feng J, Chen X, Huang Y, Chi X and Hei Z: Hyperglycemia
aggravates hepatic ischemia reperfusion injury by inducing chronic
oxidative stress and inflammation. Oxid Med Cell Longev.
2016:39196272016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bhogal RH, Curbishley SM, Weston CJ, Adams
DH and Afford SC: Reactive oxygen species mediate human hepatocyte
injury during hypoxia/reoxygenation. Liver Transpl. 16:1303–1313.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gracia-Sancho J, Villarreal GJ Jr, Zhang
Y, Yu JX, Liu Y, Tullius SG and García-Cardeña G: Flow cessation
triggers endothelial dysfunction during organ cold storage
conditions: Strategies for pharmacologic intervention.
Transplantation. 90:142–149. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tsung A, Klune JR, Zhang X, Jeyabalan G,
Cao Z, Peng X, Stolz DB, Geller DA, Rosengart MR and Billiar TR:
HMGB1 release induced by liver ischemia involves Toll-like receptor
4 dependent reactive oxygen species production and calcium-mediated
signaling. J Exp Med. 204:2913–2923. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsung A, Sahai R, Tanaka H, Nakao A, Fink
MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA and Billiar TR:
The nuclear factor HMGB1 mediates hepatic injury after murine liver
ischemia-reperfusion. J Exp Med. 201:1135–1143. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong Y, Undyala VV, Gottlieb RA, Mentzer
RJ Jr and Przyklenk K: Autophagy: Definition, molecular machinery,
and potential role in myocardial ischemia-reperfusion injury. J
Cardiovasc Pharmacol Ther. 15:220–230. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu A, Fang H, Dahmen U and Dirsch O:
Chronic lithium treatment protects against liver
ischemia/reperfusion injury in rats. Liver Transpl. 19:762–772.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang JH, Ahn IS, Fischer TD, Byeon JI,
Dunn WA Jr, Behrns KE, Leeuwenburgh C and Kim JS: Autophagy
suppresses age-dependent ischemia and reperfusion injury in livers
of mice. Gastroenterology. 141:2188–2199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang JH, Behrns KE, Leeuwenburgh C and Kim
JS: Critical role of autophage in ischemia/reperfusion injury to
aged livers. Autophagy. 8:140–141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim JS, Nitta T, Mohuczy D, O'Malley KA,
Moldawer LL, Dunn WA Jr and Behrns KE: Impaired autophagy: A
mechanism of mitochondrial dysfunction in anoxic rat hepatocytes.
Hepatology. 47:1725–1736. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu A, Fang H, Wei W, Dirsch O and Dahmen
U: Ischemic preconditioning protects against liver
ischemia/reperfusion injury via heme oxygenase-1-mediated
autophagy. Crit Care Med. 42:e762–e771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhang R, Zhang L, Manaenko A, Ye Z, Liu W
and Sun X: Helium preconditioning protects mouse liver against
ischemia and reperfusion injury through the PI3K/Akt pathway. J
Hepatol. 61:1048–1055. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Arico S, Petiot A, Bauvy C, Dubbelhuis PF,
Meijer AJ, Codogno P and Ogier-Denis E: The tumor suppressor PTEN
positively regulates macroautophagy by inhibiting the
phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol
Chem. 276:35243–35246. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Matsui Y, Takagi H, Qu X, Abdellatif M,
Sakoda H, Asano T, Levine B and Sadoshima J: Distinct roles of
autophagy in the heart during ischemia and reperfusion: Roles of
AMP-activated protein kinase and Beclin 1 in mediating autophagy.
Circ Res. 100:914–922. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Inoki K, Li Y, Zhu T, Wu J and Guan KL:
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR
signalling. Nat Cell Biol. 4:648–657. 2002. View Article : Google Scholar : PubMed/NCBI
|
